ACAD Annual EBIT
-$73.38 M
+$150.22 M+67.18%
31 December 2023
Summary:
As of January 23, 2025, ACAD annual earnings before interest & taxes is -$73.38 million, with the most recent change of +$150.22 million (+67.18%) on December 31, 2023. During the last 3 years, it has risen by +$213.21 million (+74.40%). ACAD annual EBIT is now -586.15% below its all-time high of $15.70 million.ACAD EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACAD Quarterly EBIT
$31.64 M
+$1.21 M+3.97%
30 September 2024
Summary:
As of January 23, 2025, ACAD quarterly earnings before interest & taxes is $31.64 million, with the most recent change of +$1.21 million (+3.97%) on September 30, 2024. Over the past year, it has increased by +$89.42 million (+154.77%). ACAD quarterly EBIT is now -9.44% below its all-time high of $34.94 million, reached on December 31, 2023.ACAD Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACAD TTM EBIT
$112.23 M
+$89.42 M+391.94%
30 September 2024
Summary:
As of January 23, 2025, ACAD TTM earnings before interest & taxes is $112.23 million, with the most recent change of +$89.42 million (+391.94%) on September 30, 2024. Over the past year, it has increased by +$266.62 million (+172.70%). ACAD TTM EBIT is now at all-time high.ACAD TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACAD EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +67.2% | +154.8% | +172.7% |
| 3 y3 years | +74.4% | +306.8% | +158.2% |
| 5 y5 years | +70.3% | +169.7% | +145.5% |
ACAD EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +67.2% | -9.4% | +128.0% | at high | +150.2% |
| 5 y | 5-year | at high | +74.4% | -9.4% | +128.0% | at high | +139.2% |
| alltime | all time | -586.1% | +74.9% | -9.4% | +128.0% | at high | +136.1% |
ACADIA Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $31.64 M(+4.0%) | $112.23 M(+391.9%) |
| June 2024 | - | $30.44 M(+100.1%) | $22.82 M(-597.6%) |
| Mar 2024 | - | $15.21 M(-56.5%) | -$4.58 M(-93.8%) |
| Dec 2023 | -$73.38 M(-67.2%) | $34.94 M(-160.5%) | -$73.38 M(-52.5%) |
| Sept 2023 | - | -$57.78 M(-2002.4%) | -$154.39 M(+21.1%) |
| June 2023 | - | $3.04 M(-105.7%) | -$127.48 M(-22.3%) |
| Mar 2023 | - | -$53.58 M(+16.3%) | -$164.16 M(-26.6%) |
| Dec 2022 | -$223.60 M(+31.2%) | -$46.06 M(+49.2%) | -$223.60 M(+0.6%) |
| Sept 2022 | - | -$30.87 M(-8.3%) | -$222.19 M(+7.5%) |
| June 2022 | - | -$33.65 M(-70.2%) | -$206.63 M(-4.6%) |
| Mar 2022 | - | -$113.02 M(+153.1%) | -$216.68 M(+27.1%) |
| Dec 2021 | -$170.44 M(-40.5%) | -$44.66 M(+191.9%) | -$170.44 M(-11.7%) |
| Sept 2021 | - | -$15.30 M(-65.0%) | -$192.94 M(-26.8%) |
| June 2021 | - | -$43.71 M(-34.5%) | -$263.54 M(-0.1%) |
| Mar 2021 | - | -$66.77 M(-0.6%) | -$263.84 M(-7.9%) |
| Dec 2020 | -$286.59 M(+16.2%) | -$67.16 M(-21.8%) | -$286.59 M(+3.9%) |
| Sept 2020 | - | -$85.90 M(+95.2%) | -$275.82 M(+17.2%) |
| June 2020 | - | -$44.01 M(-50.8%) | -$235.34 M(-5.3%) |
| Mar 2020 | - | -$89.52 M(+58.7%) | -$248.43 M(+0.8%) |
| Dec 2019 | -$246.54 M(-0.4%) | -$56.40 M(+24.2%) | -$246.54 M(-4.2%) |
| Sept 2019 | - | -$45.42 M(-20.4%) | -$257.42 M(-5.8%) |
| June 2019 | - | -$57.09 M(-34.9%) | -$273.27 M(-2.5%) |
| Mar 2019 | - | -$87.63 M(+30.3%) | -$280.26 M(+13.3%) |
| Dec 2018 | -$247.44 M(-15.4%) | -$67.28 M(+9.8%) | -$247.44 M(-1.1%) |
| Sept 2018 | - | -$61.27 M(-4.4%) | -$250.18 M(-1.7%) |
| June 2018 | - | -$64.08 M(+16.9%) | -$254.55 M(-1.5%) |
| Mar 2018 | - | -$54.82 M(-21.7%) | -$258.51 M(-11.6%) |
| Dec 2017 | -$292.41 M(+7.2%) | -$70.01 M(+6.6%) | -$292.41 M(-2.7%) |
| Sept 2017 | - | -$65.64 M(-3.5%) | -$300.63 M(-2.2%) |
| June 2017 | - | -$68.04 M(-23.3%) | -$307.39 M(-1.2%) |
| Mar 2017 | - | -$88.72 M(+13.4%) | -$311.27 M(+14.1%) |
| Dec 2016 | -$272.81 M(+65.7%) | -$78.23 M(+8.1%) | -$272.81 M(+13.6%) |
| Sept 2016 | - | -$72.40 M(+0.7%) | -$240.15 M(+16.2%) |
| June 2016 | - | -$71.92 M(+43.1%) | -$206.75 M(+18.6%) |
| Mar 2016 | - | -$50.26 M(+10.3%) | -$174.32 M(+5.9%) |
| Dec 2015 | -$164.61 M(+76.6%) | -$45.56 M(+16.8%) | -$164.61 M(+11.5%) |
| Sept 2015 | - | -$39.00 M(-1.3%) | -$147.60 M(+10.5%) |
| June 2015 | - | -$39.50 M(-2.6%) | -$133.60 M(+15.3%) |
| Mar 2015 | - | -$40.55 M(+42.0%) | -$115.82 M(+24.2%) |
| Dec 2014 | -$93.23 M(+143.4%) | -$28.55 M(+14.2%) | -$93.23 M(+21.3%) |
| Sept 2014 | - | -$24.99 M(+15.1%) | -$76.84 M(+22.6%) |
| June 2014 | - | -$21.72 M(+21.0%) | -$62.66 M(+25.1%) |
| Mar 2014 | - | -$17.96 M(+47.6%) | -$50.09 M(+30.8%) |
| Dec 2013 | -$38.30 M | -$12.16 M(+12.5%) | -$38.30 M(+16.2%) |
| Sept 2013 | - | -$10.81 M(+18.1%) | -$32.95 M(+34.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2013 | - | -$9.16 M(+48.6%) | -$24.55 M(+17.9%) |
| Mar 2013 | - | -$6.16 M(-9.6%) | -$20.82 M(-0.3%) |
| Dec 2012 | -$20.89 M(-8.6%) | -$6.82 M(+183.3%) | -$20.89 M(+7.8%) |
| Sept 2012 | - | -$2.41 M(-55.7%) | -$19.38 M(-12.2%) |
| June 2012 | - | -$5.43 M(-12.9%) | -$22.07 M(-5.0%) |
| Mar 2012 | - | -$6.23 M(+17.3%) | -$23.22 M(+1.6%) |
| Dec 2011 | -$22.85 M(-251.4%) | -$5.31 M(+4.3%) | -$22.85 M(-297.2%) |
| Sept 2011 | - | -$5.09 M(-22.6%) | $11.59 M(-6.8%) |
| June 2011 | - | -$6.58 M(+12.3%) | $12.44 M(-15.5%) |
| Mar 2011 | - | -$5.86 M(-120.1%) | $14.73 M(-2.4%) |
| Dec 2010 | $15.09 M(-133.2%) | $29.13 M(-786.7%) | $15.10 M(-166.4%) |
| Sept 2010 | - | -$4.24 M(-1.3%) | -$22.74 M(-16.6%) |
| June 2010 | - | -$4.30 M(-21.8%) | -$27.27 M(-23.8%) |
| Mar 2010 | - | -$5.50 M(-36.9%) | -$35.80 M(-21.3%) |
| Dec 2009 | -$45.47 M(-32.1%) | -$8.71 M(-0.8%) | -$45.47 M(-10.8%) |
| Sept 2009 | - | -$8.77 M(-31.6%) | -$50.97 M(-12.5%) |
| June 2009 | - | -$12.82 M(-15.5%) | -$58.29 M(-9.6%) |
| Mar 2009 | - | -$15.17 M(+6.7%) | -$64.51 M(-4.8%) |
| Dec 2008 | -$66.98 M(+6.9%) | -$14.21 M(-11.7%) | -$67.78 M(-6.2%) |
| Sept 2008 | - | -$16.09 M(-15.5%) | -$72.28 M(-2.4%) |
| June 2008 | - | -$19.04 M(+3.3%) | -$74.08 M(+9.5%) |
| Mar 2008 | - | -$18.44 M(-1.4%) | -$67.64 M(+8.0%) |
| Dec 2007 | -$62.65 M(+27.7%) | -$18.70 M(+4.5%) | -$62.65 M(+9.0%) |
| Sept 2007 | - | -$17.89 M(+42.0%) | -$57.50 M(+10.3%) |
| June 2007 | - | -$12.60 M(-6.3%) | -$52.15 M(-0.5%) |
| Mar 2007 | - | -$13.45 M(-0.7%) | -$52.41 M(+6.8%) |
| Dec 2006 | -$49.05 M(+37.0%) | -$13.55 M(+8.1%) | -$49.05 M(+6.2%) |
| Sept 2006 | - | -$12.54 M(-2.5%) | -$46.20 M(-0.6%) |
| June 2006 | - | -$12.86 M(+27.4%) | -$46.48 M(+15.9%) |
| Mar 2006 | - | -$10.10 M(-5.6%) | -$40.11 M(+12.0%) |
| Dec 2005 | -$35.81 M(+37.2%) | -$10.70 M(-16.5%) | -$35.81 M(+10.0%) |
| Sept 2005 | - | -$12.81 M(+97.3%) | -$32.56 M(+24.9%) |
| June 2005 | - | -$6.49 M(+12.0%) | -$26.07 M(+2.4%) |
| Mar 2005 | - | -$5.80 M(-22.2%) | -$25.46 M(-2.4%) |
| Dec 2004 | -$26.09 M(+89.9%) | -$7.46 M(+17.9%) | -$26.09 M(-31.2%) |
| Sept 2004 | - | -$6.32 M(+7.4%) | -$37.91 M(+27.5%) |
| June 2004 | - | -$5.89 M(-8.5%) | -$29.75 M(+14.8%) |
| Mar 2004 | - | -$6.43 M(-66.6%) | -$25.90 M(+19.1%) |
| Dec 2003 | -$13.74 M(+8.8%) | -$19.27 M(-1144.9%) | -$21.75 M(+777.5%) |
| Sept 2003 | - | $1.84 M(-190.3%) | -$2.48 M(-42.7%) |
| June 2003 | - | -$2.04 M(-10.5%) | -$4.32 M(+89.5%) |
| Mar 2003 | - | -$2.28 M | -$2.28 M |
| Dec 2002 | -$12.63 M(-17.4%) | - | - |
| Dec 2001 | -$15.28 M(+35.6%) | - | - |
| Dec 2000 | -$11.27 M | - | - |
FAQ
- What is ACADIA Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals annual EBIT year-on-year change?
- What is ACADIA Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly EBIT year-on-year change?
- What is ACADIA Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals TTM EBIT year-on-year change?
What is ACADIA Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of ACAD is -$73.38 M
What is the all time high annual EBIT for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual earnings before interest & taxes is $15.70 M
What is ACADIA Pharmaceuticals annual EBIT year-on-year change?
Over the past year, ACAD annual earnings before interest & taxes has changed by +$150.22 M (+67.18%)
What is ACADIA Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of ACAD is $31.64 M
What is the all time high quarterly EBIT for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly earnings before interest & taxes is $34.94 M
What is ACADIA Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, ACAD quarterly earnings before interest & taxes has changed by +$89.42 M (+154.77%)
What is ACADIA Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of ACAD is $112.23 M
What is the all time high TTM EBIT for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high TTM earnings before interest & taxes is $112.23 M
What is ACADIA Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, ACAD TTM earnings before interest & taxes has changed by +$266.62 M (+172.70%)